Skip Navigation

Vaccine Safety Bibliography - February 2012

1.   Meeting of the Strategic Advisory Group of Experts on Immunization, November 2011 - conclusions and recommendations. Wkly Epidemiol Rec. 2012 Jan 6:1-16.

2.  The value of HPV vaccination. Nat Med. 2012 Jan 6; 18(1):28-9.

3.   A pathway to leadership for adult immunization: recommendations of the national vaccine advisory committee: approved by the national vaccine advisory committee on june 14, 2011. Public Health Rep. 2012 Jan; 127 Suppl 1:1-42.

4.   Aaby P, Martins C, Benn CS, Whittle H. The new decade of vaccines. Lancet. 2012 Jan 7; 379(9810):25-6; author reply 27.

5.   Adams P. Haiti prepares for cholera vaccination but concerns remain. Lancet. 2012 Jan 7; 379(9810):16.

6.   Adetifa IM, Antonio M, Okoromah CA, Ebruke C, Inem V, Nsekpong D, Bojang A, Adegbola RA. Pre-vaccination nasopharyngeal pneumococcal carriage in a nigerian population: epidemiology and population biology. PLoS One. 2012; 7(1):e30548.

7.   Al Jumaah S, Al Hajjar S, Al Mousa H. Bacille Calmette-Guérin Vaccination in Saudi Arabia: Benefits versus Risks. Ann Saudi Med. 2012 Jan; 32(1):1-3.

8.   Al-Jassir FF, Aldeeri RA, Alsiddiky AM, Zamzam MM. Osteomyelitis following Bacille Calmette-Guerin vaccination. Saudi Med J. 2012 Jan; 33(1):87-90.

9.   Al-Tawfiq JA. Willingness of health care workers of various nationalities to  accept H1N1 (2009) pandemic influenza A vaccination. Ann Saudi Med. 2012 Jan; 32(1):64-7.

10. Andrawis MA, Rehm SJ. Health-system pharmacists' role in improving immunization rates. Am J Health Syst Pharm. 2012 Jan 1; 69(1):74-6.

11.  Ansaldi F, de Florentiis D, Durando P, Icardi G. Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults. Expert Rev Vaccines. 2012 Jan; 11(1):17-25.

12.  Atkins KE, Shim E, Pitzer VE, Galvani AP. Impact of rotavirus vaccination on  epidemiological dynamics in England and Wales. Vaccine. 2012 Jan 11; 30(3):552-64.

13.  Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; the CISA Network. Recurrent Guillain-Barre Syndrome Following Vaccination. Clin Infect Dis. 2012 Jan 19. [Epub ahead of print].

14.  Berger LC, Blog D, Birkhead GS. Mandatory HPV vaccination. JAMA. 2012 Jan 18; 307(3):253-4; author reply 254-5.

15.  Bilcke J, Marais C, Ogunjimi B, Willem L, Hens N, Beutels P. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60years in Belgium. Vaccine. 2012 Jan 11; 30(3):675-84.

16.  Buijs SC, Boersma B. [Cardiorespiratory events after first immunization in premature infants: a prospective cohort study]. Ned Tijdschr Geneeskd. 2012; 156(3):A3797.

17.  By A, Sobocki P, Forsgren A, Silfverdal SA. Comparing health outcomes and costs of general vaccination with pneumococcal conjugate vaccines in sweden: a markov model. Clin Ther. 2012 Jan; 34(1):177-89.

18.  Camenga DR, Kyanko K, Stepczynski J, Flaherty-Hewitt M, Curry L, Sewell D, Smart C, Rosenthal MS. Increasing adult tdap vaccination rates by vaccinating infant caregivers in the pediatric office. Acad Pediatr. 2012 Jan; 12(1):20-5.

19.  Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of  maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012 Jan; 54(1):78-84.

20.  Charles M, Kumar P. Re: Influenza immunization in egg allergy: an update for  the 2011-2012 season - A comparison with 'GREEN Book', Department of Health UK guideline. Clin Exp Allergy. 2012 Jan; 42(1):167.

21.  Chen SC, Hawkins G, Aspinall E, Patel N. Factors influencing uptake of influenza A (H1N1) vaccine amongst healthcare workers in a regional pediatric centre: lessons for improving vaccination rates. Vaccine. 2012 Jan 5; 30(2):493-7.

22.  Chen X, Shah D, Kositratna G, Manstein D, Anderson RR, Wu MX. Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J Control Release. 2012 Jan 9. [Epub ahead of print].

23.  Chlibek R, Anca I, André F, Ci×man M, Ivaskeviciene I, Mangarov A, Mészner Z, Perenovska P, Pokorn M, Prymula R, Richter D, Salman N, Simurka P, Tamm E, Tešoviæ G, Urbancikova I, Zavadska D, Usonis V. Adult vaccination in 11 Central European countries - Calendars are not just for children. Vaccine. 2012 Jan 5. [Epub ahead of print].

24.  Chu VT, Berek C. Immunization induces activation of bone marrow eosinophils required for plasma cell survival. Eur J Immunol. 2012 Jan; 42(1):130-7.

25.  Cramer J, Mac T, Hogan B, Stauga S, Eberhardt S, Wichmann O, Mertens T, Burchard G. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany. Euro Surveill. 2012 Jan 12; 17(2).

26.  Czerkinsky C, Holmgren J. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Curr Top Microbiol Immunol. 2012; 354:1-18.

27.  Daku M, Raub A, Heymann J. Maternal leave policies and vaccination coverage:  A global analysis. Soc Sci Med. 2012 Jan; 74(2):120-4.

28.  Dauner JG, Pan Y, Hildesheim A, Kemp TJ, Porras C, Pinto LA. Development and  application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals. Mol Cell Probes. 2012 Jan 18. [Epub ahead of print].

29.  Davis MA, Smith M, Weeks WB. Influenza vaccination among chiropractic patients and other users of complementary and alternative medicine: Are chiropractic patients really different? Prev Med. 2012 Jan 1; 54(1):5-8.

30.  de Waure C, Veneziano MA, Cadeddu C, Capizzi S, Specchia ML, Capri S, Ricciardi W. Economic value of influenza vaccination. Hum Vaccin Immunother. 2012 Jan 1; 8(1). [Epub ahead of print].

31.  deBruyn JC, Hilsden R, Fonseca K, Russell ML, Kaplan GG, Vanderkooi O, Wrobel I. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis. 2012 Jan; 18(1):25-33.

32.  Dolan SM, Cox S, Tepper N, Ruddy D, Rasmussen SA, Macfarlane K. Pharmacists'  knowledge, attitudes, and practices regarding influenza vaccination and treatment of pregnant women. J Am Pharm Assoc (2003). 2012 Jan 1; 52(1):43-51.

33.  Dombkowski KJ, Harrington LB, Dong S, Clark SJ. Seasonal influenza vaccination reminders for children with high-risk conditions: a registry-based randomized trial. Am J Prev Med. 2012 Jan; 42(1):71-5.

34.  Dorell CG, Stokley S, Yankey D, Markowitz LE. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009. Vaccine. 2012 Jan 11; 30(3):503-5.

35.  Ellison AM, Ota KV, McGowan KL, Smith-Whitley K. Pneumococcal Bacteremia in a Vaccinated Pediatric Sickle Cell Disease Population. Pediatr Infect Dis J. 2012 Jan 5. [Epub ahead of print].

36.  Fatiregun AA, Okoro AO. Maternal determinants of complete child immunization  among children aged 12-23 months in a southern district of Nigeria. Vaccine. 2012 Jan 17; 30(4):730-6.

37.  Ferdinands JM, Shay DK. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. Clin Infect Dis. 2012 Jan; 54(1):25-32.

38.  Fisker AB, Aaby P, Bale C, Balde I, Biering-Sørensen S, Agergaard J, Martins C, Bibby BM, Benn CS. Does the effect of vitamin A supplements depend on vaccination status? An observational study from Guinea-Bissau. BMJ Open. 2012 Jan 12; 2(1):e000448.

39.  Floyd MW, Boyce BM, Castellan RM, McDonough EB. Pseudoseptic arthritis of the shoulder following pneumococcal vaccination. Orthopedics. 2012 Jan 16; 35(1):e101-3.

40.  Freiesleben de Blasio B, Iversen BG, Scalia Tomba G. Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. PLoS One. 2012; 7(1):e30018.

41.  Friedrichs I, Doerr HW, Allwinn R. [Measles: immunity and vaccination status in Greater Frankfurt on the Main]. Dtsch Med Wochenschr. 2012 Jan; 137(4):121-5.

42.  Garcia S, Lagos R, Muñoz A, Picón T, Rosa R, Alfonso A, Abriata G, Gentile A, Romanin V, Regueira M, Chiavetta L, Agudelo CI, Castañeda E, De la Hoz F, Higuera AB, Arce P, Cohen AL, Verani J, Zuber P, Gabastou JM, Pastor D, Flannery B, Andrus J. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries. Vaccine. 2012 Jan 5; 30(2):486-92.

43.  Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.  Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs. 2012 Jan 1; 72(1):35-48.

44.  Gavrielov-Yusim N, Battat E, Neumann L, Friger M, Balicer RD. Birth order and private voluntary immunization--a study of 110,902 children. Vaccine. 2012 Jan5; 30(2):442-7.

45.  Gilkey MB, Brewer NT. Mandatory HPV vaccination. JAMA. 2012 Jan 18; 307(3):252-3; author reply 254-5.

46.  Girard DZ. Recommended or mandatory pertussis vaccination policy in developed countries: Does the choice matter? Public Health. 2012 Jan 4. [Epub ahead of print].

47.  Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, Schaffner W, Talbot TR. A Comparison of 2 Strategies to Prevent Infection Following Pertussis Exposure in Vaccinated Healthcare Personnel. Clin Infect Dis. 2012 Jan 11. [Epub ahead of print].

48.  Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, Randriamanalina B, Luman ET. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar.Trop Med Int Health. 2012 Jan 24.

49.  Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P,Heilmann C. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012 Jan 25; 307(4):391-7.

50.  Groenewold M, Baron S, Tak S, Allred N. Influenza Vaccination Coverage Among  US Nursing Home Nursing Assistants: The Role of Working Conditions. J Am Med Dir Assoc. 2012 Jan; 13(1):85.e17-23.

51.  Hachey K. The new decade of vaccines. Lancet. 2012 Jan 7; 379(9810):27.

52.  Holton A, Weberling B, Clarke CE, Smith MJ. The Blame Frame: Media Attribution of Culpability About the MMR-Autism Vaccination Scare. Health Commun. 2012 Jan 11. [Epub ahead of print].

53.  Hwang YH, Kang MS, Lim KO, Lee SM. Toxic epidermal necrolysis with ocular involvement following vaccination for hemorrhagic fever with renal syndrome. Yonsei Med J. 2012 Jan; 53(1):228-30.

54.  Iorio AM, Bistoni O, Galdiero M, Lepri E, Camilloni B, Russano AM, Neri M, Basileo M, Spinozzi F. Influenza viruses and cross-reactivity in healthy adults:  Humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus. Vaccine. 2012 Jan 13. [Epub ahead of print].

55.  Kang HY, Kim KH, Kim JH, Kim HM, Kim J, Kim MS, El Khoury AC, Kim DS. Economic Evaluation of the National Immunization Program of Rotavirus Vaccination for Children in Korea. Asia Pac J Public Health. 2012 Jan 10. [Epub ahead of print].

56.  Kempe A, Wortley P, O'Leary S, Crane LA, Daley MF, Stokley S, Babbel C, Dong  F, Beaty B, Seewald L, Suh C, Dickinson LM. Pediatricians' Attitudes About Collaborations With Other Community Vaccinators in the Delivery of Seasonal Influenza Vaccine. Acad Pediatr. 2012 Jan; 12(1):26-35.

57.  Kim SH, Pezzoli L, Yacouba H, Coulibaly T, Djingarey MH, Perea WA, Wierzba TF. Whom and Where Are We Not Vaccinating? Coverage after the Introduction of a New Conjugate Vaccine against Group A Meningococcus in Niger in 2010. PLoS One. 2012; 7(1):e29116.

58.  Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR. Delivery systems  for intradermal vaccination. Curr Top Microbiol Immunol. 2012; 351:77-112.

59.  Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, Morales A,  Abdulla F, Xing L, Navi D, Tibshirani RJ, Advani RH, Lingala B, Shah S, Hoppe RT, Levy R. In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood. 2012 Jan 12; 119(2):355-63.

60.  King JC Jr, Beckett D, Snyder J, Cummings GE, King BS, Magder LS. Direct and  indirect impact of influenza vaccination of young children on school absenteeism. Vaccine. 2012 Jan 5; 30(2):289-93.

61.  Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine. 2012 Jan 11; 30(3):523-38.

62.  Kitazawa Y, Warabi Y, Bandoh M, Takahashi T, Matsubara S. Elderly-Onset Neuromyelitis Optica which Developed after the Diagnosis of Prostate Adenocarcinoma and Relapsed after a 23-Valent Pneumococcal Polysaccharide Vaccination. Intern Med. 2012; 51(1):103-7.

63.  Klein NP, Reisinger KS, Johnston W, Odrljin T, Gill CJ, Bedell L, Dull P. Safety and Immunogenicity of a Novel Quadrivalent Meningococcal CRM-conjugateVaccine Given Concomitantly With Routine Vaccinations in Infants. Pediatr Infect Dis J. 2012 Jan; 31(1):64-71.

64.  Knuf M, Pankow-Culot H, Grunert D, Rapp M, Panzer F, Köllges R, Fanic A, Habib A, Borys D, Dieussaert I, Schuerman L. Induction of Immunologic Memory Following Primary Vaccination With the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Infants. Pediatr Infect Dis J. 2012 Jan; 31(1):e31-e36.

65.  Kotton CN, Poznansky MC. Vaccination of oncology patients: an effective tool and an opportunity not to be missed. Oncologist. 2012; 17(1):1-2.

66.  Krawczyk AL, Perez S, Lau E, Holcroft CA, Amsel R, Knäuper B, Rosberger Z. Human papillomavirus vaccination intentions and uptake in college women. Health Psychol. 2012 Jan 23. [Epub ahead of print].

67.  Kuhnert R, Schlaud M, Poethko-Müller C, Vennemann M, Fleming P, Blair PS, Mitchell E, Thompson J, Hecker H. Reanalyses of case-control studies examining the temporal association between sudden infant death syndrome and vaccination. Vaccine. 2012 Jan 27. [Epub ahead of print].

68.  Ledford CJ, Willett KL, Kreps GL. Communicating immunization science: the genesis and evolution of the national network for immunization information. JHealth Commun. 2012 Jan; 17(1):105-22.

69.  Lessin HR, Edwards KM; the COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE AND THE COMMITTEE ON INFECTIOUS DISEASES. Immunizing Parents and Other Close Family Contacts in the Pediatric Office Setting. Pediatrics. 2012 Jan; 129(1):e247-e253.

70.  Li HT, Lu S, Liu JM. Herpes Zoster Vaccination in People Aged 50-59 Years. Clin Infect Dis. 2012 Jan 30. [Epub ahead of print].

71.  Li M, Chapman GB, Ibuka Y, Meyers LA, Galvani A. Who got vaccinated against H1N1 pandemic influenza? - A longitudinal study in four US cities. Psychol Health. 2012 Jan; 27(1):101-15.

72.  Lin CC, Yang CY, Shih YL, Huang YY, Yang TH, Liang JY, Chang CF, Hsieh HS, Huang YL. Persistence and Titer Changes of Rubella Virus Antibodies in Primiparous Women Who Had Been Vaccinated with Strain RA 27/3 in Junior High School. Clin Vaccine Immunol. 2012 Jan; 19(1):1-4.

73.  Lismond A, Carbonnelle S, Verhaegen J, Schatt P, De Bel A, Jordens P, Jacobs  F, Dediste A, Verschuren F, Huang TD, Tulkens PM, Glupczynski Y, Van Bambeke F. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinatedand non-vaccinated patients with a clinically confirmed diagnosis ofcommunity-acquired pneumonia in Belgium. Int J Antimicrob Agents. 2012 Jan 13. [Epub ahead of print].

74.  Lopes CC, Berezin EN, Scheffer D, Huziwara R, Sliva MI, Brandão A, Guerra ML, Brandileone MC. Pneumococcal Nasopharyngeal Carriage in Infants of Mothers Immunized with 23V Non-conjugate Pneumococcal Polysaccharide Vaccine. J Trop Pediatr. 2012 Jan 18. [Epub ahead of print].

75.  Maitani Y, Ishikawa H. Effectiveness assessment of vaccination policy against measles epidemic in Japan using an age-time two-dimensional mathematical model. Environ Health Prev Med. 2012 Jan; 17(1):34-43.

76.  Maple PA, Breuer J, Quinlivan M, Kafatos G, Brown KE. Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference  time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera  from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers. J Clin Virol. 2012 Jan 17. [Epub ahead  of print].

77.  Mayet A, Nivoix P, Haus-Cheymol R, De Laval F, Verret C, Duron S, Faure N, Piarroux M, Decam C, Chaudet H, Meynard JB, Deparis X, Migliani R. Increase inreported adverse events following seasonal influenza vaccination among the Frencharmed forces, 2008-2009: Possible role of stimulated reporting and backgroundcases of influenza-like infection. Public Health. 2012 Jan; 126(1):70-6.

78.  McNeela EA, Lavelle EC. Recent advances in microparticle and nanoparticle delivery vehicles for mucosal vaccination. Curr Top Microbiol Immunol. 2012; 354:75-99.

79.  Melmed GY. Vaccinations while on thiopurines: some protection is better than  none. Am J Gastroenterol. 2012 Jan; 107(1):141-2.

80.  Melmed GY. Immunizations and IBD: whose responsibility is it? If I'm the prescribing doctor, shouldn't it be mine? Inflamm Bowel Dis. 2012 Jan; 18(1):41-2.

81.  Mendes MF, Valladares Neto Dde C, Azevedo RA, Caramelli P. Narcolepsy after A/H1N1 vaccination. Clinics (Sao Paulo). 2012; 67(1):77-8.

82.  Mollema L, Wijers N, Hahne SJ, van der Klis FR, Boshuizen HC, de Melker HE. Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires. BMC Public Health. 2012 Jan 20; 12(1):57. [Epub ahead of print].

83.  Moreno-Pérez D, Arístegui Fernández J, Ruiz-Contreras J, Alvarez García FJ, Merino Moína M, González-Hachero J, Corretger Rauet JM, Hernández-Sampelayo Matos T, Ortigosa Del Castillo L, Cilleruelo Ortega MJ, Barrio Corrales F. [Seasonal influenza vaccination in children and adolescents. Recommendations of the CAV-AEP for the campaign]. An Pediatr (Barc). 2012 Jan; 76(1):44.e1-5.

84.  Morley EJ, Lapoint JM, Roy LW, Cantor R, Grant WD, Paolo WF, Wojcik S. Rates  of Positive Blood, Urine, and Cerebrospinal Fluid Cultures in Children Younger Than 60 Days During the Vaccination Era. Pediatr Emerg Care. 2012 Jan 20. [Epub ahead of print].

85.  Muhsen K, El-Hai RA, Amit-Aharon A, Nehama H, Gondia M, Davidovitch N, Goren S, Cohen D. Risk factors of underutilization of childhood immunizations in ultraorthodox Jewish communities in Israel despite high access to health care services. Vaccine. 2012 Jan 25. [Epub ahead of print].

86.  Mullins TL, Zimet GD, Rosenthal SL, Morrow C, Ding L, Shew M, Fortenberry JD, Bernstein DI, Kahn JA. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med. 2012 Jan; 166(1):82-8.

87.  Murphy PA, Frazee SG, Cantlin JP, Cohen E, Rosan JR, Harshburger DE. Pharmacy provision of influenza vaccinations in medically underserved communities. J Am Pharm Assoc (2003). 2012 Jan 1; 52(1):67-70.

88.  Nan X. Communicating to Young Adults About HPV Vaccination: Consideration of Message Framing, Motivation, and Gender. Health Commun. 2012 Jan; 27(1):10-8.

89.  Nevin RL. Confounding and bias in studies of DMSS vaccination data. Vaccine. 2012 Jan 5. [Epub ahead of print].

90.  Nguyen M, Ball R, Midthun K, Lieu TA. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:291-7.

91.  Nikolopoulos G, Tsiodras S, Bonovas S. Influenza vaccination: Cassandra's prophecy. Public Health. 2012 Jan; 126(1):82-3.

92.  O'Keefe DJ, Nan X. The Relative Persuasiveness of Gain- and Loss-Framed Messages for Promoting Vaccination: A Meta-Analytic Review. Health Commun. 2012 Jan 31. [Epub ahead of print].

93.  Olivier CW. Influenza vaccination coverage rate in children: Reasons for a failure and how to go forward. Hum Vaccin Immunother. 2012 Jan 1; 8(1).  [Epub ahead of print].

94.  Omer SB, Bednarczyk R, Madhi SA, Klugman KP. Benefits to mother and child of influenza vaccination during pregnancy. Hum Vaccin Immunother. 2012 Jan 1; 8(1). [Epub ahead of print].

95.  Opel DJ, Robinson JD, Heritage J, Korfiatis C, Taylor JA, Mangione-Smith R. Characterizing providers' immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study. Vaccine. 2012 Jan 9. [Epub ahead of print].

96.  Ouandaogo CR, Yaméogo TM, Diomandé FV, Sawadogo C, Ouédraogo B, Ouédraogo-Traoré R, Pezzoli L, Djingarey MH, Mbakuliyemo N, Zuber PL. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010. Vaccine. 2012 Jan 6. [Epub ahead of print].

97.  Pahud BA, Rowhani-Rahbar A, Glaser C, Gavali S, Salibay CJ, Fireman B, Dekker CL. Lack of association between childhood immunizations and encephalitis in California, 1998-2008. Vaccine. 2012 Jan 5; 30(2):247-53.

98.  Palli SR, Mehta S, Aparasu RR. Prevalence and predictors of human papillomavirus vaccination in adolescent girls. J Am Pharm Assoc (2003). 2012 Jan

99.  Perdan-Pirkmajer K, Thallinger G, Snoj N, Cucnik S, Zigon P, Kveder T, Logar D, Praprotnik S, Tomsic M, Sodin-Semrl S, Ambrozic A. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease. Lupus. 2012; 21(2):175-83.

100. Pereira JA, Quach S, Hamid JS, Heidebrecht CL, Quan SD, Nassif J, Diniz AJ,  Van Exan R, Malawski J, Gentry A, Finkelstein M, Guay M, Buckeridge DL, Bettinger JA, Kalailieff D, Kwong JC; for the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group. Exploring the feasibility of integrating barcode scanning technology into vaccine inventory recording in seasonal influenza vaccination clinics. Vaccine. 2012 Jan 17; 30(4):794-802.

101. Perricone C, Agmon-Levin N, Valesini G, Shoenfeld Y. Vaccination in patients with chronic or autoimmune rheumatic diseases: The ego, the id and the superego.  Joint Bone Spine. 2012 Jan; 79(1):1-3.

102. Pezzoli L, Tchio R, Dzossa AD, Ndjomo S, Takeu A, Anya B, Ticha J, Ronveaux  O, Lewis RF. Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009. Epidemiol Infect. 2012 Jan; 140(1):14-26.

103. Polisena J, Chen Y, Manuel D. The proportion of influenza vaccination in Ontario, Canada in 2007/2008 compared with other provinces. Vaccine. 2012 Jan 14. [Epub ahead of print].

104. Pool V, Gordon DM, Decker M. Methodological issues with the risk of relapse  study in patients with multiple sclerosis after yellow Fever vaccination. Arch Neurol. 2012 Jan; 69(1):144.

105. Pruvost I, Lowingerova-Fauvet S, Debacker P, Dervaux B, Dubos F, Martinot A. [Assessment of primary care physicians' adherence to the national childhood vaccination schedule.]. Arch Pediatr. 2012 Jan 18. [Epub ahead of print].

106. Quan K, Tehrani DM, Dickey L, Spiritus E, Hizon D, Heck K, Samuelson P, Kornhauser E, Zeitany R, Mancia S, Thrupp L, Tiso SM, Huang SS. Voluntary to mandatory: evolution of strategies and attitudes toward influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):63-70.

107. Rainey JJ, Lacapère F, Danovaro-Holliday MC, Mung K, Magloire R, Kananda G, Cadet JR, Lee CE, Chamouillet H, Luman ET. Vaccination Coverage in Haiti: Results from the 2009 National Survey. Vaccine. 2012 Jan 3. [Epub ahead of print].

108. Redelings MD, Piron J, Smith LV, Chan A, Heinzerling J, Sanchez KM, Bedair D, Ponce M, Kuo T. Knowledge, attitudes, and beliefs about seasonal influenza and H1N1 vaccinations in a low-income, public health clinic population. Vaccine. 2012 Jan 5; 30(2):454-8.

109. Reed JL, Scott DE, Bray M. Eczema Vaccinatum. Clin Infect Dis. 2012 Jan 30.  [Epub ahead of print].

110. Rivera-Ordaz A, Gonzaga-Bernachi J, Serafín-López J, Hernández-Pando R, Van Soolingen D, Estrada-Parra S, Estrada-García I, Chacón-Salinas R. Mycobacterium tuberculosis Beijing genotype induces differential cytokine production by peripheral blood mononuclear cells of healthy BCG vaccinated individuals. Immunol Invest. 2012; 41(2):144-56.

111. Ropero-Álvarez AM, Whittembury A, Kurtis HJ, Dos Santos T, Danovaro-Holliday MC, Ruiz-Matus C. Pandemic influenza vaccination: Lessons learned from Latin America and the Caribbean. Vaccine. 2012 Jan 20; 30(5):916-21.

112. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol. 2012 Jan; 86(1):615-20.

113. Salazar M, Stinson KE, Sillau SH, Good L, Newman LS. Web-based electronic health records improve data completeness and reduce medical discrepancies in employee vaccination programs. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):84-6.

114. Santibanez TA, Shefer A, Briere EC, Cohn AC, Groom AV. Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States. Vaccine. 2012 Jan 20; 30(5):941-7.

115. Sanvicens N, Varela B, Ballesteros B, Marco MP. Development of an immunoassay for terbutryn: Study of the influence of the immunization protocol. Talanta. 2012 Jan 30; 89:310-6.

116. Sawyer MH, Peddecord KM, Wang W, Deguire M, Miskewitch-Dzulynsky M, Vuong DD. A public health initiative to increase annual influenza immunization among hospital health care personnel: The San Diego Hospital Influenza Immunization Partnership. Am J Infect Control. 2012 Jan 20. [Epub ahead of print].

117. Schäppi MG, Meier S, Bel M, Siegrist CA, Posfay-Barbe KM; the H1N1 Study Group. Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children with Celiac Disease. J Pediatr Gastroenterol Nutr. 2012 Jan 4. [Epub ahead of print].

118. Shah SM, Carey IM, Harris T, DeWilde S, Cook DG. The impact of dementia on influenza vaccination uptake in community and care home residents. Age Ageing. 2012 Jan; 41(1):64-9.

119. Shahrabani S, Benzion U. How Experience Shapes Health Beliefs: The Case of Influenza Vaccination. Health Educ Behav. 2012 Jan 27. [Epub ahead of print].

120. Shann F. The new decade of vaccines. Lancet. 2012 Jan 7; 379(9810):26; author Reply 27.

121. Shefer A, Strikas R, Bridges CB. Updated recommendations of the Advisory Committee on Immunization Practices for healthcare personnel vaccination: a necessary foundation for the essential work that remains to build successful programs. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):71-4.

122. Simell B, Nurkka A, Lahdenkari M, Givon-Lavi N, Käyhty H, Dagan R, Jokinen J. Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with  a 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol. 2012 Jan; 19(1):96-9.

123. Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW. Early Impact of the US Tdap Vaccination Program on Pertussis Trends. Arch Pediatr Adolesc Med. 2012 Jan 11. [Epub ahead of print].

124. Soldevilla H, Briones S, Navarra S. Systemic lupus erythematosus following HPV immunization or infection? Lupus. 2012; 21(2):158-61.

125. Soofi SB, Haq IU, Khan MI, Siddiqui MB, Mirani M, Tahir R, Hussain I, Puri MK, Suhag ZH, Khowaja AR, Lasi AR, Clemens JD, Favorov M, Ochiai RL, Bhutta ZA. Schools as potential vaccination venue for vaccines outside regular EPI schedule: results from a school census in Pakistan. BMC Res Notes. 2012 Jan 6; 5:6.

126. Soriano A, Verrecchia E, Marinaro A, Giovinale M, Fonnesu C, Landolfi R, Manna R. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus. 2012; 21(2):153-7.

127. Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T; The LYSISTRATA Study Group. Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine. Arch Gynecol Obstet. 2012 Jan 14. [Epub ahead of print].

128. Stewart B, Zhang Y, Rose Jr CE, Tokars JI, Martin SW, Franzke LH, McNeil MM. Health-related quality of life in the Anthrax Vaccination Program for workers in  the Laboratory Response Network. Vaccine. 2012 Jan 9. [Epub ahead of print].

129. Sánchez-Payá J, Hernández-García I, García-Román V, Camargo-Angeles R, Barrenengoa-Sañudo J, Villanueva-Ruiz CO, Martínez HR, González-Hernández M. Influenza vaccination among healthcare personnel after pandemic influenza H1N1. Vaccine. 2012 Jan 20; 30(5):911-5.

130. Talbot HK, Libster R, Edwards K. Influenza vaccination for older adults. HumVaccin Immunother. 2012 Jan 1; 8(1). [Epub ahead of print].

131. Tan X, Chun S, Pablo J, Felgner P, Liang X, Davies DH. Failure of smallpox vaccine to take in vaccinia-naive individuals is related to differences in antibody profiles before vaccination, not after. Clin Vaccine Immunol. 2012 Jan18. [Epub ahead of print].

132. Tomljenovic L, Shaw CA. Mandatory HPV vaccination. JAMA. 2012 Jan 18; 307(3):254; author reply 254-5.

133. Toussirot E, Bossert M, Herbein G, Saas P. Comments on the article by Tabache F. et al. "Acute polyarthritis after influenza A H1N1 immunization", Joint Bone Spine, 2011, Primary Sjögren's syndrome occurring after influenza A H1N1 vaccine administration. Joint Bone Spine. 2012Jan; 79(1):107.

134. Tully SP, Anonychuk AM, Sanchez DM, Galvani AP, Bauch CT. Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada. Vaccine. 2012 Jan 5; 30(2):425-35.

135. Turner N. The challenge of improving immunization coverage: the New Zealand  example. Expert Rev Vaccines. 2012 Jan; 11(1):9-11.

136. Uddin MJ, Saha NC, Islam Z, Khan IA, Shamsuzzaman, Quaiyum MA, Koehlmoos TP. Improving low coverage of child immunization in rural hard-to-reach areas of Bangladesh: findings from a project using multiple interventions. Vaccine. 2012 Jan 5; 30(2):168-79.

137. Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM, Poland GA. Associations Between Demographic Variables and Multiple Measles-Specific Innate and Cell-Mediated Immune Responses After Measles Vaccination. Viral Immunol. 2012 Jan 12. [Epub ahead of print]

138. Vaca M, Moncayo AL, Cosgrove CA, Chico ME, Castello-Branco LR, Lewis DJ, Cooper PJ. A Single Dose of Oral BCG Moreau Fails to Boost Systemic IFN-γ Responses to Tuberculin in Children in the Rural Tropics: Evidence for a Barrier to Mucosal Immunization. J Trop Med. 2012; 2012:132583.

139. van Assen S, Bijl M. Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations). Lupus. 2012; 21(2):162-7.

140. van der Meer H, van Zwol A, Spanjaard L, van Furth AM. [An infant with meningitis caused by resistant pneumococcus: infection despite vaccination]. Ned  Tijdschr Geneeskd. 2012; 156(1):A3806.

141. Vanderkooi OG, Scheifele DW, Girgenti D, Halperin SA, Patterson SD, Gruber WC, Emini EA, Scott DA, Kellner JD; for the Canadian PCV13 Study Group. Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada. Pediatr Infect Dis J. 2012 Jan; 31(1):72-77.

142. Veltri K, Yaghdjian V, Morgan-Joseph T, Prlesi L, Rudnick E. Hospital emergency preparedness: Push-POD operation and pharmacists as immunizers. J Am Pharm Assoc (2003). 2012 Jan 1; 52(1):81-5.

143. Venkat A, Hunter R, Hegde GG, Chan-Tompkins NH, Chuirazzi DM, Szczesiul JM.  Perceptions of Participating Emergency Nurses Regarding an ED Seasonal Influenza Vaccination Program. J Emerg Nurs. 2012 Jan; 38(1):22-9.

144. Vestrheim DF, Steinbakk M, Aaberge IS, Caugant DA. Post-vaccination increase of serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex. Clin Vaccine Immunol. 2012 Jan 11. [Epub ahead of print].

145. Vista E, Crowe S, Thompson L, Air G, Robertson J, Guthridge J, James J. Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus. Lupus. 2012; 21(2):168-174.

146. Walther B, Miles DJ, Waight P, Palmero MS, Ojuola O, Touray ES, Whittle H, van der Sande M, Crozier S, Flanagan KL. Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCGvaccination. BMC Infect Dis. 2012 Jan 14; 12(1):6. [Epub ahead of print].

147. Weber DJ, Consoli SA, Sickbert-Bennett E, Rutala WA. Assessment of a mandatory tetanus, diphtheria, and pertussis vaccination requirement on vaccine uptake over time. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):81-3.

148. Weiss R, Scheiblhofer S, Roesler E, Weinberger E, Thalhamer J. mRNA vaccination as a safe approach for specific protection from type I allergy. Expert Rev Vaccines. 2012 Jan; 11(1):55-67.

149. Yasuda H, Nagata M, Moriyama H, Kobayashi H, Akisaki T, Ueda H, Hara K, Yokono K. Development of fulminant Type 1 diabetes with thrombocytopenia after influenza vaccination: a case report. Diabet Med. 2012 Jan; 29(1):88-9.

150. Yeung JH, Goodman KJ, Fedorak RN. Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis. 2012 Jan; 18(1):34-40.

151. Zastrow A, Schnitzler P, Eckerle I, Herzog W, Friederich HC. Immunogenicity  and safety of H1N1 vaccination in anorexia nervosa--results from a pilot study.Int J Eat Disord. 2012 Jan; 45(1):146-9.